BELLOTTI, VITTORIO
 Distribuzione geografica
Continente #
NA - Nord America 6.576
AS - Asia 4.990
EU - Europa 4.488
SA - Sud America 598
AF - Africa 63
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.731
Nazione #
US - Stati Uniti d'America 6.456
CN - Cina 2.921
IE - Irlanda 1.110
SG - Singapore 1.004
UA - Ucraina 608
HK - Hong Kong 591
FI - Finlandia 553
BR - Brasile 500
RU - Federazione Russa 497
DE - Germania 479
IT - Italia 361
SE - Svezia 271
GB - Regno Unito 258
VN - Vietnam 174
FR - Francia 130
IN - India 78
CA - Canada 70
PL - Polonia 47
BE - Belgio 38
AR - Argentina 36
MX - Messico 36
TR - Turchia 32
JP - Giappone 30
BD - Bangladesh 29
ES - Italia 26
NL - Olanda 19
ZA - Sudafrica 19
IQ - Iraq 16
EC - Ecuador 15
CZ - Repubblica Ceca 14
CO - Colombia 13
ID - Indonesia 13
MA - Marocco 12
AT - Austria 11
VE - Venezuela 11
IR - Iran 10
KR - Corea 10
UZ - Uzbekistan 10
LT - Lituania 9
PE - Perù 9
KE - Kenya 8
SA - Arabia Saudita 8
LV - Lettonia 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
DK - Danimarca 6
KG - Kirghizistan 6
MU - Mauritius 6
NZ - Nuova Zelanda 6
RO - Romania 6
TH - Thailandia 6
EG - Egitto 5
HU - Ungheria 5
JM - Giamaica 5
PK - Pakistan 5
PY - Paraguay 5
AU - Australia 4
AZ - Azerbaigian 4
CH - Svizzera 4
GR - Grecia 4
IL - Israele 4
PT - Portogallo 4
AL - Albania 3
HR - Croazia 3
JO - Giordania 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
MD - Moldavia 3
MY - Malesia 3
OM - Oman 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
CL - Cile 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EU - Europa 2
KZ - Kazakistan 2
LB - Libano 2
NI - Nicaragua 2
NP - Nepal 2
PH - Filippine 2
SN - Senegal 2
TW - Taiwan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DZ - Algeria 1
GT - Guatemala 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
MK - Macedonia 1
MN - Mongolia 1
Totale 16.722
Città #
Dublin 1.108
Chandler 1.033
Jacksonville 752
Nanjing 665
Hong Kong 590
Dallas 565
Beijing 520
Ashburn 467
Singapore 460
Boardman 318
Nanchang 277
Princeton 222
Shenyang 202
Wilmington 200
Hebei 185
Lawrence 184
Ann Arbor 176
Changsha 174
Helsinki 157
Los Angeles 157
Medford 154
Jiaxing 135
New York 107
Tianjin 106
Munich 104
Buffalo 95
Hangzhou 95
Moscow 88
Milan 86
Shanghai 75
Woodbridge 75
Redondo Beach 71
Ho Chi Minh City 62
Turku 51
São Paulo 49
Pavia 46
Verona 42
Falls Church 40
The Dalles 40
Brussels 37
Hanoi 35
Warsaw 32
Norwalk 30
Chicago 29
Santa Clara 29
Denver 28
Piscataway 27
Toronto 27
Fairfield 26
Brooklyn 24
Orem 24
Seattle 24
Tokyo 24
Stockholm 23
Montreal 21
Frankfurt am Main 20
London 20
Phoenix 20
Houston 19
Jinan 19
Rio de Janeiro 19
Falkenstein 18
Guangzhou 18
Ankara 17
Boston 17
Chennai 17
San Francisco 17
Atlanta 16
Belo Horizonte 16
Auburn Hills 15
Mexico City 15
Washington 15
Johannesburg 14
Charlotte 12
Kunming 12
Ningbo 12
Poplar 12
Mumbai 11
Zhengzhou 11
Rome 10
Sassari 10
Columbus 9
Curitiba 9
Fuzhou 9
Porto Alegre 9
Secaucus 9
Tashkent 9
Campinas 8
Nuremberg 8
Baghdad 7
Bexley 7
Buenos Aires 7
Carney 7
Chandigarh 7
Haiphong 7
Hefei 7
Manchester 7
Taizhou 7
Bishkek 6
Campina Grande 6
Totale 10.920
Nome #
L'ipotesi della cascata amiloide nella malattia di Alzheimer: studi su strategie di neuroprotezione. 184
Susceptibility to AA amyloidosis in rheumatic diseases: A critical overview. 176
A specific nanobody prevents amyloidogenesis of D76N β2-microglobulin in vitro and modifies its tissue distribution in vivo 156
C. elegans expressing human beta2-microglobulin: a novel model for studying the relationship between the molecular assembly and the toxic phenotype. 143
Affinity capillary electrophoresis is a powerful tool to identify transthyretin binding drugs for potential therapeutic use in amyloidosis 143
D-strand perturbation and amyloid propensity in beta-2 microglobulin. 135
Hepatitis C virus-associated cryoglobulinaemicglomerulonephritis with delayed appearance of monoclonal cryoglobulinaemia. 132
Liver biopsy discloses a new apolipoprotein AI hereditary amyloidosis in several unrelated Italian families 130
Biological activity and pathological implications of misfolded proteins. 126
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. 125
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy 125
The H50Q mutation induces a tenfold decrease in the solubility of α-synuclein. 121
Class I Major Histocompatibility Complex, the Trojan horse for secretion of amyloidogenic β2-microglobulin. 118
WALDENSTROM'S HYPERGLOBULINEMIC PURPURA IN HLA IDENTICAL SISTERS. 117
Antibodies to human serum amyloid P component eliminate visceral amyloid deposits. 117
Search of ligands for the amyloidogenic protein beta(2)-microglobulin by capillary electrophoresis and other techniques 114
Identification and characterization of a new ligand-binding site in FnbB, a fibronectin-binding adhesin from Streptococcus dysgalactiae 114
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils:inhibition of amyloidogenesis. 114
Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure. 113
AL amyloidosis. Characterization of amyloidogenic cells by anti-idiotypic monoclonal antibodies 112
Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis 112
Amino acid sequence of k Sci, the Bence Jones protein isolated from a patient with light chain deposition disease. 110
Heparin strongly enhances the formation of beta 2-microglobulin amyloid fibrils in the presence of type I collagen 110
Beta 2- microglobulin can be refolded into a native state from ex vivo amyloid fibrils 109
AMYLOIDOSIS AL 109
Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. 109
Atomic structure of a nanobody trapped domain swapped dimer of an amyloidogenic β2-microglobulin variant 108
Co-fibrillogenesis of Wild-type and D76N β2-Microglobulin: THE CRUCIAL ROLE OF FIBRILLAR SEEDS 108
A partially structured species of beta 2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis 107
beta 2-microglobulin H31Y variant 3D-structure highlights the protein natural propensity towards intermolecular aggregation 106
Capillary electrophoresis investigation of a partially unfolded conformation of Beta 2-microglobulin. 106
Clinical, radiological, and biochemical features of a bilateral buttock amyloidoma emerging after 27 years of hemodialysis. 106
“Separation and quantification of two beta2-microglobulin isoforms”. 105
Sulfonated molecules that bind a partially structured species of beta2-microglobulin also influence refolding and fibrillogenesis. 105
Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. 104
Characterization of the two unique human anti-flavin monoclonal immunoglobulins. 104
DE loop mutations affect beta2-microglobulin stability and amyloid aggregation 102
Biochimica Applicata 102
Amyloid persistence in decellularized liver: Biochemical and histopathological characterization 102
Use of an anti-idiotypic monoclonal antibody in studying amyloidogenic light chains in cells, urine and fibrils: pathophysiology and clinical implications. 101
4'-Iodo-4'-deoxydoxorubicin disrupts the fibrillar structure of transthyretin amyloid 101
Effects of the Known Pathogenic Mutations on the Aggregation Pathway of the Amyloidogenic Peptide of Apolipoprotein A-I. 101
Use of anti-(beta2 microglobulin) mAb to study formation of amyloid fibrils 100
A recurrent D-strand association interface is observed in β-2 microglobulin oligomers. 100
Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis. 100
Enhanced toxicity of silver nanoparticles in transgenic Caenorhabditis elegans expressing amyloidogenic proteins 100
Effect of tetracyclines on the dynamics of formation and destructuration of {beta}2-microglobulin amyloid fibrils. 100
Capillary electrophoresis studies on the aggregation process of beta-amyloid 1-42 and 1-40 peptides 99
Structural characterization of kappa II Inc, a new amyloid immunoglobulin 99
USE OF A MONOCLONAL ANTIBODY AGAINST HUMAN HEART FERRITIN FOR EVALUATING ACIDIC FERRITIN CONCENTRATION IN HUMAN SERUM 98
Metodo per la separazione e la quantificazione di due conformazioni di beta-2-microglobulina in equilibrio dinamico 98
The two tryptophans of β2-microglobulin have distinct roles in function and folding and might represent two independent responses to evolutionary pressure. 95
Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients 94
Antiamyloidogenic and proamyloidogenic chaperone effects of C-reactive protein and serum amyloid P component 94
Amyloid Formation by Globular Proteins: The Need to Narrow the Gap Between in Vitro and in Vivo Mechanisms 94
CHRONIC LYMPHOCYTIC LEUKAEMIA OR IDIOPATHIC COLD HAEMAGGLUTININ DISEASE? A DILEMMA RAISED BY AN ERRONEOUS ELECTRONIC CELL COUNT 92
Plasminogen activation triggers transthyretin amyloidogenesis in vitro 92
IMMUNOENZYMATIC DETECTION OF PROTEINS TRANSFERRED ON NITROCELLULOSE AFTER FIXATION AND STAINING IN POLYACRYLAMIDE GEL 91
Defect of platelet aggregation and adhesion induced by autoantibody against glycoprotein IIIa. 91
Cerebrospinal fluid ferritin in human disease. 91
A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis 91
C. elegans expressing D76N β2-microglobulin: a model for in vivo screening of drug candidates targeting amyloidosis 91
Fibrillogenesis of human beta2-microglobulin in three-dimensional silicon microstructures 91
Inhibition of the mechano-enzymatic amyloidogenesis of transthyretin: role of ligand affinity, binding cooperativity and occupancy of the inner channel. 90
Conformational dynamics of the beta2-microglobulin C terminal in the cell-membrane-anchored major histocompatibility complex type I 90
Citrate-stabilized gold nanoparticles hinder fibrillogenesis of a pathological variant of β2-microglobulin 89
Proteomics of beta2-microglobulin amyloid fibrils. 88
Detection of two partially structured species in the folding process of the amyloidogenic protein beta 2-microglobulin 87
Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases. 87
An Asp to Asn mutation is a toxic trigger in beta-2 microglobulin: structure and biophysics 87
Nanobodies against beta2-microglobulin. 86
Cinetiche di refolding e studi di affinità mediante elettroforesi capillare: effetto di ligandi di interesse farmaceutico sulla conformazione della Beta 2-microglobulina 86
Collagen plays an active role in the aggregation of beta 2-microglobulin under physio-pathological conditions of dialysis-related amyloidosis. 85
Development of a method to screen potential ligands of amyloidogenic proteins 85
Biochemical and Electrophysiological Modification of Amyloid Transthyretin on Cardiomyocytes. 85
Comparative study of the stabilities of synthetic in vitro and natural ex vivo transthyretin amyloid fibrils 85
Conformational transition and cellular toxicity by amyloidogenic proteins 84
AN INTERLEUKIN 2 BINDING FACTOR IN HUMAN SERUM 84
Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman's disease. 84
Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation 84
AA amyloidosis without systemic inflammation: when clinical evidence validates predictions of experimental medicine 84
Enhanced molecular chaperone activity of the small heat-shock protein αB-crystallin following covalent immobilization onto a solid-phase support. 83
CHARACTERIZATION OF ANTI-STREPTOLYSIN O ACTIVITY OF A HUMAN MONOCLONAL IgG LAMDA. 82
Application of monoclonal anti-idiotypes in the study of AL amyloidosis: therapeutic implication 82
DETECTION OF FRAGMENTS OF BETA2-MICROGLOBULIN IN AMYLOID FIBRILS 82
STUDY OF THREE PATIENTS WITH MONOCLONAL GAMMAPATHIES AND "LUPUS-LIKE" ANTICOAGULANTS. 81
Anatomic and Clinical Clues to in vivo mechanisms of amyloidogenesis. in , (2005) vol. 1, pp.29-48. 81
Bifunctional crosslinking ligands for transthyretin 81
Membrane CD22 defines circulating myeloma-related cells as mature or later B cells 81
Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosis 81
Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin. 81
D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile 81
Binding of Monovalent and Bivalent Ligands by Transthyretin Causes Different Short- And Long-Distance Conformational Changes 81
RELEVANCE OF CLASS, MOLECULAR WEIGHT AND ISOELECTRIC POINT IN PREDICTING HUMAN LIGHT CHAIN AMYLOIDOGENICITY. 80
Topological investigation of amyloid fibrils obtained from beta2-microglobulin 79
Rational design of mutations that change the aggregation rate of a protein while maintaining its native structure and stability 79
Conformational dynamics in crystals reveal the molecular bases for D76N beta-2 microglobulin aggregation propensity 79
Structural and folding dynamics properties of T70N variant of human lysozyme. 79
Preliminary crystallographic characterization of the human beta2 microglobulin His31Tyr mutant in a tetrameric assembly. 78
The controlling roles of Trp60 and Trp95 in beta2-microglobulin function, folding and amyloid aggregation properties. 78
Totale 10.022
Categoria #
all - tutte 73.883
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.883


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021744 0 0 0 0 0 161 8 183 49 167 144 32
2021/2022905 15 7 11 13 28 56 18 64 58 36 132 467
2022/20233.045 365 239 26 219 315 280 0 160 1.307 20 64 50
2023/2024968 136 202 40 57 104 222 12 48 8 41 69 29
2024/20252.973 71 240 78 94 76 111 113 222 779 91 336 762
2025/20263.724 536 499 823 782 842 242 0 0 0 0 0 0
Totale 16.989